Operating cash flow swung from negative $64 million to positive $738 million in eleven quarters, yet the stock fell 47% from its peak — a turnaround story the market refuses to believe. The legends see the same recovery but draw opposite conclusions about whether a business generating $2.49 billion in free cash flow can trade at 66x EBITDA.
The cash generation machine is undeniable — all frameworks acknowledge extraordinary financial engineering
$2.49B free cash flow, 32% FCF margins, zero stock-based compensation in Q4'25 — efficiency metrics that all five legends highlight as exceptional.
Management conviction speaks louder than analyst downgrades
Net insider buying of 75,761 shares worth ~$27 million during the 47% drawdown — Buffett, Marks, and Lynch all cite this as meaningful signal amid market pessimism.
The valuation disconnect is historic, not hypothetical
Market implies 1.02% perpetual growth vs 12.3% trailing FCF growth — an 11-point expectations gap that Mauboussin, Marks, and Graham all identify as extreme mispricing.
Is a 0.90% earnings yield acceptable when treasuries pay 4.33%?
Growth justifies the premium to risk-free rates
12.3% FCF growth and improving margins warrant equity risk premium — the 3.43% spread will close through multiple expansion, not compression.
No margin of safety exists at any growth rate
66x EBITDA eliminates downside protection — Graham sees 111 years of earnings priced in, Lynch calculates a PEG of 3.6, both violations of value discipline.
Does insider buying at decade-low valuations signal opportunity or desperation?
Management sees mispricing others miss
124,844 shares bought vs 19,227 sold in Q1'26, plus Windacre's $1.38B position — smart money accumulating at 15th percentile of 52-week range.
Even insiders can't fight valuation gravity
Stock down 47% despite insider buying — at 66x EBITDA, no amount of conviction overcomes mathematical reality of the valuation.
The 35-point spread masks deeper disagreement — the bulls see a mispriced compounder while the bears see an overvalued stalwart, with no middle ground on whether 66x EBITDA can ever offer value.
All five frameworks miss Roper's unusual positive correlation with interest rates (0.80) — while everyone debates traditional valuation metrics, the company actually thrives in the very rate environment that's crushing its multiple. The business model appears structurally advantaged for higher-rate regimes, yet trades as if rates are its enemy.
If operating cash flow can swing from negative $64 million to positive $738 million while the stock falls 47%, what exactly would it take for the market to care about fundamentals again?